What is Amrutanjan Health Care Ltd (AMRUTANJAN) share price return in the past 10 years?

Amrutanjan Health Care Ltd share price has appreciated 10.4% annually (CAGR) over the past ten years.

What is the share price of Amrutanjan Health Care Ltd (AMRUTANJAN)?

Company share prices are keep on changing according to the market conditions. The current trading price of Amrutanjan Health Care Ltd (AMRUTANJAN) on 04-Jun-2026 16:59:59 at 16:59 is 545.45.

What is the P/E ratio of Amrutanjan Health Care?

The latest standalone P/E ratio of Amrutanjan Health Care as of 04-Jun-2026 is 27.23.

What is the P/B ratio of Amrutanjan Health Care Ltd (AMRUTANJAN)?

The latest standalone P/B ratio of Amrutanjan Health Care Ltd (AMRUTANJAN) as of 04-Jun-2026 is 4.26.

What is the 52-week high and low of Amrutanjan Health Care Ltd (AMRUTANJAN)?

The 52-week high of Amrutanjan Health Care Ltd (AMRUTANJAN) is Rs. 789.95 and the 52-week low is Rs. 490.00.

Amrutanjan Health Care Ltd (AMRUTANJAN) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Amrutanjan Health Care Ltd (AMRUTANJAN)
Brand: Amrutanjan Health Care

Amrutanjan Health Care Ltd (AMRUTANJAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590006 NSE: AMRUTANJAN Pharmaceuticals & Drugs | Small Cap | Amrutanjan Healthcar Share Price

Amrutanjan Health Care Ltd (AMRUTANJAN)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 590006 NSE: AMRUTANJAN Pharmaceuticals & Drugs | Small Cap | Amrutanjan Healthcar Share Price

Key Metrics

Valuation Multiples

Market Cap

₹1,577 Cr.

Current Price

₹545.5

52-Week Low / High

₹490 / 790

TTM EPS

₹20

TTM Sales

₹503 Cr.

Book Value per Share

₹128.1

P/E Ratio

27.23

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

4.26

Lower than its 5-year historical median

Price to Sales (P/S)

3.14

Lower than its 5-year historical median

EV/EBITDA

16.55

Lower than its 5-year historical median

Dividend Yield

0.71%

Profitability Efficiency

Return on Equity (ROE)

16.53%

Outperforms industry median

Return on Capital Employed (ROCE)

22.58%

Outperforms industry median

Return on Assets (ROA)

13.00%

Operating Profit Margin

12.9%

Net Profit Margin

11.25%

Gross Profit Margin

16.8%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

7.26%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

12.33%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

13.03%

Asset Quality

Promoter Holding

46.52%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹367 Cr.

Equity

₹2.9 Cr.

Face Value

₹1

All Time Low / High

₹5.05 / 1025.55

Amrutanjan Health Care stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is Amrutanjan Health Care Ltd a good quality company?

Amrutanjan Health Care Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Amrutanjan Health Care Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Amrutanjan Health Care Ltd vs industry peers?

Amrutanjan Health Care Ltd revenue CAGR is 11.56%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Amrutanjan Health Care Ltd?

Promoters hold 46.52% of the Amrutanjan Health Care Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Amrutanjan Health Care Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 10.3% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	30.9%	28.7%	27%	25.4%	22.8%	44%	37.9%	19.4%	21.5%	22.6%	-
Value Creation Index ⓘ	1.2	1.1	0.9	0.8	0.6	2.1	1.7	0.4	0.5	0.6	-
Growth Parameters ⓘ
Sales ⓘ	184	212	220	253	261	333	406	380	421	452	503
Sales YoY Gr.	-	14.8%	4%	15.2%	3.2%	27.3%	21.9%	-6.5%	11%	7.3%	-
Adj EPS ⓘ	7.5	7.5	6.4	8.4	8.6	20.9	23	13.6	15.5	17.6	20
YoY Gr.	-	0.3%	-14.9%	31.4%	2%	144.9%	9.8%	-40.8%	14.1%	13.2%	-
BVPS (₹) ⓘ	41.2	39.6	44	49.9	54.5	73.5	90.5	99.1	99.9	112.8	128.1
Adj Net Profit ⓘ	21.9	21.9	18.7	24.5	25	61.2	67.2	39.8	44.9	50.8	58
Cash Flow from Ops. ⓘ	21.4	8.3	19.1	21.2	18.2	90.9	52.2	20.2	27.9	50.9	-
Debt/CF from Ops. ⓘ	0	0.3	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.5%	11.6%	3.6%	7.3%
Adj EPS ⓘ	10%	15.5%	-8.6%	13.2%
BVPSⓘ	11.8%	15.7%	7.6%	12.9%
Share Price	10.4%	-5.1%	-2.7%	-24.6%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	19.4	18.6	15.3	17.9	16.4	32.7	28	14.3	15.5	16.5	16.6
Op. Profit Mgn % ⓘ	17.1	14.2	12.9	12.2	11.8	20.3	19.1	11.8	12.4	12.9	15.1
Net Profit Mgn % ⓘ	11.9	10.4	8.5	9.7	9.6	18.4	16.6	10.5	10.7	11.3	11.5
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	123	122	111	81	125	115	130	208	224	224	100
Cash Conv. Cycle ⓘ	43	24	12	14	19	-7	-12	0	6	5	66

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	184	212	220	253	261	333	406	380	421	452
Operating Expenses ⓘ +	153	182	192	222	231	266	328	335	369	394
Manufacturing Costs	37	7	17	16	17	18	29	34	35	35
Material Costs	37	87	96	119	117	140	180	182	212	223
Employee Cost	28	30	34	33	39	42	48	49	48	59
Other Costs ⓘ	51	57	45	54	57	66	71	71	75	76
Operating Profit ⓘ	32	30	28	31	31	67	78	45	52	58
Operating Profit Margin (%)	17.1%	14.1%	12.9%	12.2%	11.8%	20.2%	19.1%	11.7%	12.3%	12.9%
Other Income ⓘ +	6	7	8	7	8	19	17	15	16	18
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	1	0	0	0	1	1	0	0	0
Depreciation ⓘ	3	3	3	3	4	4	4	5	6	7
Profit Before Tax ⓘ	35	34	33	35	34	82	91	54	62	69
Tax ⓘ	12	12	13	10	9	21	23	14	17	18
Profit After Tax	22	22	20	25	25	61	67	40	45	51
PAT Margin (%)	12.2%	10.3%	9.1%	9.7%	9.6%	18.4%	16.6%	10.5%	10.7%	11.3%
Adjusted EPS (₹)	7.7	7.5	6.9	8.4	8.6	20.9	23.0	13.6	15.6	17.6
Dividend Payout Ratio (%)	25.10%	25.80%	28.40%	25.60%	24.50%	20.10%	20%	33.80%	29.60%	26.20%

Valuation of Amrutanjan Healthcar - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	120	116	129	146	159	215	265	290	289	326
Share Capital ⓘ	3	3	3	3	3	3	3	3	3	3
Reserves ⓘ	118	113	126	143	157	212	262	287	286	323
Debt +	0	2	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	2	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	9	25	26	30	31	41	60	47	56	69
Others Liabilities ⓘ	19	5	7	8	10	15	21	21	19	23
Total Liabilities ⓘ	149	149	162	183	201	271	346	358	364	418
Fixed Assets
Net Fixed Assets ⓘ +	22	27	28	26	26	23	28	49	50	49
Gross Block	39	30	33	35	39	39	48	74	76	82
Accumulated Depreciation	16	3	6	9	13	16	19	25	26	32
CWIP ⓘ	1	1	0	0	0	2	17	1	2	16
Investments ⓘ	10	10	8	18	18	18	13	5	0	0
Inventories	8	10	10	15	24	17	26	29	29	27
Trade Receivables	26	29	28	33	26	18	38	33	48	56
Cash Equivalents	48	31	73	81	36	139	88	70	27	83
Others Assets ⓘ	34	42	16	11	70	54	136	170	208	186
Total Assets ⓘ	149	149	162	183	201	271	346	358	364	418

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	21	8	19	21	18	91	52	20	28	51
PBT ⓘ	35	34	33	35	34	82	91	54	62	69
Adjustment ⓘ	-2	-0	-4	-3	-1	-3	-10	-8	-7	-9
Changes in Working Capital ⓘ	1	-11	0	-1	-4	31	-4	-10	-10	9
Tax Paid ⓘ	-11	-14	-11	-10	-11	-19	-24	-16	-16	-18
Cash Flow From Investing Activity ⓘ +	1	-0	-8	-11	-14	-88	-36	-2	19	-31
Capex	-1	-4	-1	-2	-3	-2	-23	-9	-6	-36
Net Investments	0	-1	-13	-14	-17	-92	-25	-5	12	-11
Others ⓘ	3	4	6	5	6	6	13	11	14	16
Cash Flow From Financing Activity ⓘ +	-11	-5	-9	-7	-12	-7	-17	-15	-48	-13
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	1	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0	-1	-0	-0	-0	-0	0	0	0	0
Dividend Paid ⓘ	-11	-4	-6	-6	-9	-6	-12	-14	-13	-13
Others ⓘ	0	-0	-4	-1	-2	-2	-4	-1	-36	-0
Net Cash Flow ⓘ	12	3	2	3	-7	-4	-1	3	-1	6

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	19.9	18.46	16.41	17.87	16.44	32.69	28.03	14.37	15.54	16.53
ROCE (%)	30.86	28.65	26.95	25.43	22.8	44	37.93	19.38	21.47	22.58
Asset Turnover Ratio	1.39	1.49	1.42	1.47	1.36	1.41	1.32	1.08	1.17	1.16
PAT to CFO Conversion(x)	0.95	0.36	0.95	0.84	0.72	1.49	0.78	0.5	0.62	1
Working Capital Days
Receivable Days	49.60	45.10	46.70	43.90	41.50	24.20	25.20	34.30	35.10	41.90
Inventory Days	14.30	14.80	16.80	18	26.70	22.60	19.50	26.40	25	22.70
Payable Days	80.80	71.60	98.10	86.40	95.40	93.80	102.30	108.20	89	102.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amrutanjan Health Care Ltd FAQs

The current trading price of Amrutanjan Healthcar on 04-Jun-2026 16:59 is ₹545.5.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Amrutanjan Healthcar stood at ₹1,576.9 Cr

The latest P/E ratio of Amrutanjan Healthcar as of 03-Jun-2026 is 27.23.

The latest P/B ratio of Amrutanjan Healthcar as of 03-Jun-2026 is 4.26.

The 52-week high of Amrutanjan Healthcar is ₹790.0 and the 52-week low is ₹490.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Amrutanjan Healthcar is ₹503 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Amrutanjan Health Care Ltd is a good quality company.

The key valuation ratios of Amrutanjan Health Care Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Amrutanjan Health Care Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Amrutanjan Health Care Ltd

Amrutanjan Health Care was started in the year 1893 by social reformer, journalist and freedom fighter, Nageswara Rao Pantulu Garu. Today Amrutanjan is one of the household names in South India.

While Amrutanjan Pain Balm (Yellow Balm) is the flagship brand of the company with a rich heritage of over 100 years, the company is also planning to introduce a series of next generation products in healthcare category.

With a wide range of ayurvedic and allopathic products, Amrutanjan has helped millions of people relieve themselves from the pain and discomfort of headaches, colds, sprains, muscular pains, rheumatic pains and stands a real pain management specialist for its loyal customers.

The company has diversified into various businesses in the health care segment like the Fine Chemical Division and Osmosys Medical Clinic located in Chennai. Apart from the products in the pain care segment, other categories include cough and cold care, health and home care.

Its products are available in the Gulf, African, South East and Asian countries. Plans are ready to enter the US and European markets in a big way.

Products

Amrutanjan pain balm
Dragon Roll-on liquid balm
Joint ache cream
Pain relief kit
Cold rub
Vaporising gel
Cough drops
Swas mint
Diakyur capsules
Jiffy tablets
Decorn (corn caps)
Cutis olive oil, etc.

Amrutanjan Health Care Ltd (AMRUTANJAN)

Amrutanjan Health Care Ltd (AMRUTANJAN)

Amrutanjan Health Care stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Amrutanjan Healthcar - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amrutanjan Health Care Ltd FAQs

About Amrutanjan Health Care Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Amrutanjan Health Care Ltd (AMRUTANJAN)

Amrutanjan Health Care Ltd (AMRUTANJAN)

Amrutanjan Health Care stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Amrutanjan Healthcar - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Amrutanjan Health Care Ltd FAQs

What is the share price of Amrutanjan Healthcar?

What is the market cap of Amrutanjan Healthcar?

What is the P/E ratio of Amrutanjan Healthcar?

What is the P/B ratio of Amrutanjan Healthcar?

What is the 52-week high and low of Amrutanjan Healthcar?

What is the TTM revenue of Amrutanjan Healthcar?

Is Amrutanjan Health Care Ltd a good quality company?

Is Amrutanjan Health Care Ltd undervalued or overvalued?

Is Amrutanjan Health Care Ltd a good buy now?

About Amrutanjan Health Care Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.